Amwell AI Market Strategy Report - Online Therapy

Answer Capsule

Amwell appears in 12.2% of AI observations across the online therapy category but earns a valid recommendation in only 4.7% of cases, revealing a significant gap between visibility and recommendation power. The platform holds a net sentiment score of 0.46, indicating generally positive framing when mentioned, yet its average recommended rank of 4.0 places it at the bottom of most AI-generated shortlists. Amwell's strongest performance is in the pricing and cost cluster, where it achieves its highest recommendation coverage at 8.3%, but this remains well below category leaders. The clearest opportunity is converting existing neutral and positive mentions into ranked recommendations by strengthening the public evidence layer that AI systems use to select shortlist candidates.

Who This Report Is For

This report is for Amwell's marketing, brand strategy, and growth leadership teams evaluating AI recommendation positioning in the online therapy category.

Report Card

• Report type: AI Company Market Strategy Report
• Target company: Amwell
• Category / market studied: Online Therapy
• Reporting month: June 2026
• AI platforms tracked: ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity
• Public high-intent clusters: 3 (Best Online Therapy Platforms, Online Therapy Platform Comparisons, Online Therapy Pricing and Cost)
• AI observations analyzed: 1,252
• Competitors tracked: 10

Executive Summary

Amwell occupies a difficult position in the online therapy AI recommendation landscape. The platform is visible to AI systems, appearing in 12.2% of all observations across 1,252 prompts, but it is rarely selected for buyer shortlists. With a valid recommendation coverage of just 4.7% and a top-three rate of 1.9%, Amwell is present in AI responses primarily as a contextual reference rather than a recommended choice.

The gap between presence and recommendation is the defining metric for Amwell. The platform receives 153 total mentions across all observations, with 71 positive mentions and 82 neutral mentions. No negative mentions were recorded. This pattern suggests AI systems have access to factual information about Amwell and frame it neutrally or positively, but the public evidence layer does not support confident recommendation placement.

Amwell's strongest cluster is Online Therapy Pricing and Cost, where it achieves 8.3% valid recommendation coverage and a 0.62 net sentiment score. This is the highest-intent buyer stage, carrying a 1.5x commercial multiplier, and it represents Amwell's best opportunity for near-term improvement. However, even in this cluster, Amwell's average recommended rank of 4.5 means it appears near the bottom of shortlists when it is recommended at all.

The platform's modeled monthly AI authority value of $89,455 represents just 0.4% of the total category opportunity of $21.9 million. By comparison, category leader Talkspace captures $2.32 million in modeled value, and challenger Grow Therapy captures $498,636. Amwell is not competing for AI-driven buyer attention at a meaningful scale in the online therapy category.

What Amwell Is Winning

Amwell's strongest performance is in the Online Therapy Pricing and Cost cluster. This decision-stage cluster carries the highest buyer intent and a 1.5x commercial multiplier. Amwell achieves 8.3% valid recommendation coverage here, its highest across all three public clusters, with a net sentiment score of 0.62. The platform receives 39 positive mentions out of 63 total mentions in this cluster, suggesting that when AI systems discuss Amwell in a pricing context, the framing is predominantly positive.

Amwell also shows a clean overall sentiment profile with zero negative mentions across all 1,252 observations. This is a meaningful structural advantage compared to competitors such as BetterHelp, which carries 20 negative mentions and a 1.6% negative visibility rate. Amwell's neutral and positive framing means there is no reputational drag to overcome in AI responses, which is a starting condition that takes effort to establish and can be difficult to recover once lost.

On Google AI Mode, Amwell achieves its strongest platform-level performance with 4.4% valid recommendation coverage and a 0.86 net sentiment score. This platform appears to have access to more favorable source material about Amwell than other AI systems in the tracked set.

Where Amwell Has the Clearest AI Visibility Gaps

The gap between mention presence and recommendation coverage is Amwell's most significant structural weakness. The platform appears in 12.2% of observations but earns a valid recommendation in only 4.7% of cases, meaning Amwell is referenced in AI responses more than twice as often as it is recommended. Talkspace, by comparison, appears in 70.5% of observations and earns recommendations in 33.3% of cases. Amwell's absolute presence and recommendation numbers are far lower, and the presence-to-recommendation conversion ratio is weaker.

Amwell's top-three rate of 1.9% is among the lowest in the category. Only Calmerry at 1.3% and Regain at 1.0% perform worse. When Amwell does receive a recommendation, it typically appears in the fourth position or lower, with an average recommended rank of 4.0. This means even when Amwell is recommended, it is rarely in a position that drives active buyer consideration.

The platform's rank-one rate of 0.5% is effectively negligible. Amwell earned the top recommendation position in only 6 out of 1,252 observations. Talkspace earned 163 rank-one positions and BetterHelp earned 185 across the same observation set.

On ChatGPT, Amwell's performance is particularly weak. The platform appears in 8.7% of observations but earns a valid recommendation in only 3.7% of cases, with a modeled monthly AI authority value of $1,196. This is the lowest platform-level modeled value for Amwell across all six AI systems, suggesting that ChatGPT's source layer does not currently support Amwell as a recommendation candidate at meaningful frequency.

Biggest Opportunity

Amwell's clearest opportunity is converting its existing neutral and positive mentions into ranked recommendations by strengthening the public evidence layer that AI systems use to select shortlist candidates. The platform already carries a clean sentiment profile with zero negative mentions and a 0.46 net sentiment score. The issue is not that AI systems frame Amwell negatively. The issue is that AI systems do not have enough authoritative, recommendation-ready source material to place Amwell in shortlist positions.

The pricing and cost cluster is the most actionable starting point. Amwell achieves its highest recommendation coverage here at 8.3%, and the cluster carries the highest commercial multiplier at 1.5x. Improving recommendation coverage in this cluster from 8.3% to even 15% would meaningfully increase Amwell's captured share of AI opportunity in the online therapy category. This requires building more structured comparison content, pricing guides, and clinically credible references that position Amwell as a top choice for cost-conscious therapy seekers at the decision stage.

Prompt Evidence

Google AI Mode / Online Therapy Pricing and Cost Prompt: "Compare online therapy platform pricing" Result: Amwell was mentioned alongside other platforms but appeared in a lower rank position, reflecting its average recommended rank of 4.5 in this cluster.

Copilot / Best Online Therapy Platforms Prompt: "What are the best online therapy platforms?" Result: Amwell appeared in 33.6% of Copilot observations but earned a valid recommendation in only 12.6% of cases, indicating frequent mention without consistent shortlist inclusion.

ChatGPT / Online Therapy Platform Comparisons Prompt: "Compare Talkspace, BetterHelp, and Amwell for online therapy" Result: Amwell appeared in 8.7% of ChatGPT observations with a 3.7% recommendation rate and a modeled monthly AI authority value of $1,196, the weakest platform-level performance for the brand.

Perplexity / Best Online Therapy Platforms Prompt: "List the top online therapy services" Result: Amwell appeared in 5.7% of Perplexity observations with a 3.8% recommendation rate but achieved a 0.67 net sentiment score, suggesting positive framing when mentioned even at low frequency.

What CiteWorks Studio Would Do Next

Phase 1: AI Market Discovery Audit Map Amwell's full recommendation footprint across all six AI platforms and all 10 buyer intent clusters to identify the specific prompts and platforms where competitor displacement is most acute.

Phase 2: Recommendation Readiness Plan Identify the specific source gaps preventing AI systems from recommending Amwell, including missing comparison content, clinical references, and pricing authority signals at the decision stage.

Phase 3: Owned Answer Layer Buildout Develop structured content that positions Amwell as a top choice in pricing and cost conversations, the cluster where the platform already shows its strongest recommendation signal and best conditions for improvement.

Phase 4: Citation / Authority Layer Development Build the public evidence layer across review platforms, clinical directories, and comparison sites that AI systems rely on for shortlist selection in the online therapy category.

Phase 5: Monthly AI Visibility and Recommendation Tracking Monitor Amwell's recommendation coverage, rank position, and sentiment across all platforms and clusters each month to measure improvement and adjust strategy as AI source patterns shift.

Why This Matters

Amwell is not invisible to AI systems. It appears in 12.2% of observations and carries a clean sentiment profile with no negative framing. But presence alone does not drive buyer consideration in AI-led discovery. When a therapy seeker asks an AI assistant for the best platform or compares pricing options, the AI does not list every available service. It curates a shortlist. Amwell is being mentioned, but it is not being selected for that shortlist at a rate that reflects its actual market position.

The gap between being referenced and being recommended is where Amwell is losing commercial opportunity. With a modeled monthly AI authority value of $89,455 against a category opportunity of $21.9 million, Amwell is capturing less than half a percent of the AI-driven buyer attention in its own market. The next move is not to chase more mentions. It is to build the source architecture that converts mentions into recommendations at the prompts and platforms where buyer decisions are forming.

Core Metrics

• Mentions: 153
• Valid recommendations: 59
• Top 3 recommendation count: 24
• Rank 1 recommendation count: 6
• Average recommended rank: 4.0
• Positive mentions: 71
• Neutral mentions: 82
• Negative mentions: 0
• Raw mention presence rate: 12.2%
• Valid recommendation coverage: 4.7%
• Top 3 recommendation rate: 1.9%
• Rank 1 recommendation rate: 0.5%
• Strongest cluster by recommendation behavior: Online Therapy Pricing and Cost (8.3% valid recommendation coverage)
• Strongest platform by recommendation behavior: Google AI Mode (4.4% valid recommendation coverage)

Sentiment Score

Sentiment Score = (positive mentions x 1 + neutral mentions x 0 + negative mentions x -1) / total mentions

Amwell's sentiment score: (71 x 1 + 82 x 0 + 0 x -1) / 153 = 71 / 153 = 0.46

This score means Amwell's mentions skew neutral to positive, with no negative framing recorded across any platform. However, sentiment score measures framing quality, not recommendation eligibility. A platform can be positively mentioned in an AI response and still not earn a shortlist position. The distinction between mention sentiment and recommendation coverage is critical for interpreting this data correctly. Counting all 153 mentions as commercial wins would mask the fact that Amwell earns valid recommendations in fewer than 5 out of every 100 observations. Classified sentiment is a diagnostic signal. Recommendation coverage is the commercial signal.

Sentiment by Platform

Methodology

1. This report is a benchmark-based analysis of Amwell's AI recommendation visibility in the online therapy category, powered by the LLM Authority Index 2026 AI Market Discovery Index.
2. The reporting window is June 2026, based on a snapshot of AI platform outputs captured during that period.
3. Six AI platforms were tracked: ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, and Perplexity.
4. A total of 1,252 observations were analyzed across all platforms and clusters. Unique prompt count was not available in the public dataset version used for this report.
5. The competitor universe includes 10 companies: BetterHelp, Talkspace, Grow Therapy, Brightside Health, Online-Therapy.com, 7 Cups, Amwell, Cerebral, Regain, and Calmerry.
6. Three public high-intent clusters were analyzed for this report: Best Online Therapy Platforms (consideration stage), Online Therapy Platform Comparisons (evaluation stage), and Online Therapy Pricing and Cost (decision stage). The full LLM Authority Index dataset includes 10 clusters.
7. A mention is defined as any appearance of Amwell in an AI-generated response, regardless of sentiment, rank, or framing context.
8. A valid recommendation is a positive, shortlist-quality response in which Amwell is explicitly recommended or ranked as a candidate option. Neutral references, cautionary mentions, comparison anchors, and incidental appearances do not qualify as valid recommendations.
9. Metrics used include valid recommendation coverage, top-three rate, rank-one rate, average recommended rank, net sentiment score, positive visibility rate, neutral visibility rate, negative visibility rate, modeled monthly AI authority value, and captured share of AI opportunity. Modeled values are benchmark estimates based on commercial intent signals and are not revenue figures.
10. Platform weights are equal across all six AI systems tracked. AI outputs are dynamic and can shift with model updates, source indexing changes, and prompt variation. This report reflects a point-in-time benchmark and is not a full audit or complete market census.

See How AI Is Recommending Your Brand

The benchmark shows the market shape. A company-specific analysis shows which prompts Amwell wins or loses, which AI platforms are under-recognizing the brand, which source layers are shaping recommendation decisions, and what changes may improve shortlist eligibility. CiteWorks Studio maps where your brand appears, identifies where competitors are being recommended instead, surfaces the prompts that carry the most commercial risk, and shows what needs to change to improve recommendation-stage visibility across the AI platforms where your buyers are searching.